Research
Showing of 197 results
UH Seidman Cancer Center Researchers Find Real World Data Can Inform Care for Metastatic Castration-Resistant Prostate Cancer
Findings were published in JAMA Network Open.
New Study Shows How to Protect the Brain to Prevent Depression and Cognitive Impairment Caused by Whole Brain Radiotherapy
Research team from University Hospitals, Case Western Reserve University and the Cleveland VA published results in Redox Biology.
Oxford-Harrington Rare Disease Centre Invites Proposals for 2026 Award
Prestigious Scholar Award Accelerates Novel Therapies for Patients with Rare Diseases.
UH Seidman Cancer Researchers: What is the ideal duration of hormone therapy for the treatment of prostate cancer?
Results published in JAMA Oncology.
Cleveland Researchers Discover Enzyme That Controls Both Weight Gain and Cholesterol Levels in Animal Models
New Study from University Hospitals and Case Western Reserve University published in Science Signaling.
Oxford-Harrington Rare Disease Centre Announces 2025 Scholars Advancing Promising Treatments
Ten scientists selected for second annual award to pursue innovations in gene, RNA, small molecule and cell therapies to treat rare and ultra-rare diseases.
Support from Harrington Discovery Institute at University Hospitals Helped Advance Heart Attack Drug into Clinical Trials
Positive results of zalunfiban announced at AHA Scientific Sessions.
University Hospitals Seidman Cancer Center Researchers Find Age Should Be a Consideration in Metastatic Prostate Cancer Treatment Plans
The study, published in the October 28, 2025 edition of New England Journal of Medicine Evidence, was led by senior author Daniel Spratt, MD.